Call For Papers
Journal of Alzheimer's Research and Therapy (JALR) invites impactful submissions that advance care, discovery, and understanding of neurodegenerative disease.
Publish research that moves Alzheimer's science forward
JALR welcomes original research, systematic reviews, translational studies, and clinical insights that improve diagnosis, treatment, care pathways, and health policy for Alzheimer's disease and related dementias. Our editorial scope prioritizes scientific rigor, clinical relevance, and transparency so findings can be applied across research, clinical, and community settings.
We are especially interested in work that connects bench science with patient outcomes, accelerates therapeutic development, or improves real world care for patients and caregivers.
Replication studies and well explained negative results are also valued when they strengthen the evidence base and guide future trials.
We consider a wide range of submissions that align with the mission of Journal of Alzheimer's Research and Therapy. Representative areas include, but are not limited to:
Interdisciplinary submissions are encouraged, including collaborations that connect neurology, geriatrics, psychology, nursing, health economics, and public health. We also welcome studies that evaluate real world implementation, care coordination, and community based interventions for patients and caregivers.
Original Research
Clinical, translational, or basic science studies with robust methodology and reproducible outcomes.
Systematic Reviews
Evidence syntheses following recognized reporting standards to inform practice or policy.
Short Communications
Concise reports of significant findings, novel tools, or early validation studies.
Case Reports and Clinical Insights
Well documented clinical observations that add learning value for diagnosis or care.
Methods and Protocols
Reproducible methods, pipelines, and protocols that improve study design or analysis.
Perspective and Commentary
Expert viewpoints on emerging themes, policy impacts, or innovation in dementia research.
- Open access publishing ensures your work is immediately available to researchers, clinicians, and caregivers worldwide.
- Single blind peer review prioritizes methodological quality and clinical relevance.
- Structured metadata and DOI assignment support indexing and long term discoverability.
- Responsive editorial communication and clear decision timelines support author planning.
- Dedicated editorial focus on Alzheimer's research maximizes relevance for the right audience.
JALR runs themed special issues to spotlight priority research areas or collaborative initiatives. We welcome proposals for special issues led by expert guest editors. Proposals should include a scope statement, proposed guest editor credentials, and a list of potential topics or invited contributors. Approved proposals receive editorial guidance and promotional support.
Submissions are accepted year round. Authors should review the Instructions for Author before submitting to ensure proper formatting, ethical compliance, and reporting completeness.
Quick tip: Include a concise cover letter that explains the significance of your findings for Alzheimer's research and identifies the intended audience. Clear positioning improves editorial triage and reviewer selection.
Journal of Alzheimer's Research and Therapy expects authors to follow established ethical standards for human and animal research, disclose conflicts of interest, and provide data availability statements. Clear reporting improves reproducibility and helps ensure that results can be validated and applied in clinical practice.
JALR supports authors through each step of the publishing journey with guidance on manuscript preparation, structured feedback during peer review, and responsive communication after acceptance. Our editorial team prioritizes clarity and consistency to help authors move from submission to publication efficiently.
We look for studies that demonstrate methodological transparency and real world relevance. Manuscripts that perform well during editorial assessment typically share the following characteristics:
- A clear research question linked to Alzheimer's disease mechanisms, diagnostics, treatment, or care delivery.
- Appropriate study design with transparent inclusion criteria and statistical methods.
- Results presented with sufficient detail for replication or secondary analysis.
- Discussion that explains how findings affect clinical practice, caregiver outcomes, or future research.
- Data availability and ethics statements that meet journal and funder expectations.
Journal of Alzheimer's Research and Therapy uses a single blind peer review model. Reviewers know author identities so they can assess prior work and related studies, while author identities remain protected from reviewer disclosure. We strive for efficient decisions without sacrificing rigor.
Most manuscripts move through initial screening quickly, followed by detailed peer review. Authors receive structured revision guidance, and final decisions are based on scientific merit, methodological soundness, and relevance to the journal scope.
Published articles include structured metadata, DOI assignment, and open access distribution to maximize discoverability. JALR emphasizes clear titles, focused abstracts, and keyword precision to improve indexing performance and ensure the right audiences can locate your work quickly.
Submit your manuscript to JALR
Share your Alzheimer's research with a global open access audience and contribute to progress in diagnosis, treatment, and care.
For scope questions, special issue proposals, or pre submission checks, contact the editorial office at [email protected]. Please include your manuscript title and a short abstract for faster guidance. We typically respond within two business days.
